Gemelli Biotech leverages leading biological discoveries related to the microbiome to provide non-invasive precision diagnostics which enable clinicians to definitively detect scientifically validated biomarkers and optimally treat GI diseases including SIBO, IMO, excess hydrogen sulfide and post-infectious IBS.
| Website | http://gemellibiotech.com |
| Employees | 24 (16 on RocketReach) |
| Founded | 2018 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+7 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Science and Engineering, Microbiome, Health Diagnostics, IBS Diagnostics, Health Care, Pharmaceutical |
| Keywords | Advanced Diagnostics, Microbiome Diagnostics, Innovative Diagnostics, Precision Diagnostics, Next Generation Diagnostics, Clinical Diagnostics, Cutting Edge Diagnostics, Gastrointestinal Diagnostics, Biomarker Detection, Non Invasive Diagnostics, Microbial Diagnostics, Microbiome Testing |
| Competitors | Roche, Thermo Fisher Scientific, Bristol Myers Squibb, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, PacBio, Genomatix AG +40 more (view full list) |
Looking for a particular Gemelli Biotech employee's phone or email?
Matt Mitcho is the Co-Founder and CEO of Gemelli Biotech.
16 people are employed at Gemelli Biotech.
Gemelli Biotech is based in Raleigh, North Carolina.